The US Food and Drug Administration (FDA) has cleared Arteriocyte Medical Systems' 50cc volume of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation system. The Magellan system utilizes ...
Tags: FDA, Anticoagulant Citrate Dextrose Solution, clinical technology